Amicus Therapeutics, Inc.
Символ: FOLD
NASDAQ
10.54
USDПазарна цена днес
-20.4143
Съотношение P/E
0.7032
Коефициент PEG
3.11B
MRK Cap
- 0.00%
Доходност на DIV
Amicus Therapeutics, Inc. (FOLD) финансови отчети
Баланс
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 1099.23 | 286.2 | 293.6 | 482.5 | ||||||||||||||||||||
balance-sheet.row.short-term-investments | 217.01 | 39.2 | 144.8 | 237.3 | ||||||||||||||||||||
balance-sheet.row.net-receivables | 292.86 | 87.6 | 66.2 | 52.7 | ||||||||||||||||||||
balance-sheet.row.inventory | 195.02 | 59.7 | 23.8 | 26.8 | ||||||||||||||||||||
balance-sheet.row.other-current-assets | 191.73 | 49.5 | 40.2 | 34.8 | ||||||||||||||||||||
balance-sheet.row.total-current-assets | 1778.84 | 483.1 | 423.8 | 596.8 | ||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 236.73 | 58 | 60.3 | 63.1 | ||||||||||||||||||||
balance-sheet.row.goodwill | 791.19 | 197.8 | 197.8 | 197.8 | ||||||||||||||||||||
balance-sheet.row.intangible-assets | 86.92 | 20.5 | 23 | 23 | ||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 878.11 | 218.3 | 220.8 | 220.8 | ||||||||||||||||||||
balance-sheet.row.long-term-investments | 13.44 | 3.1 | 4.3 | -4.9 | ||||||||||||||||||||
balance-sheet.row.tax-assets | -10.36 | 0 | 4.9 | 4.9 | ||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 75.82 | 15.5 | 10 | 24.4 | ||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 1193.74 | 294.8 | 300.4 | 308.3 | ||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-assets | 2972.58 | 777.9 | 724.2 | 905.1 | ||||||||||||||||||||
balance-sheet.row.account-payables | 76.76 | 15.1 | 15.4 | 21.5 | ||||||||||||||||||||
balance-sheet.row.short-term-debt | 31.93 | 8.3 | 8.6 | 7.4 | ||||||||||||||||||||
balance-sheet.row.tax-payables | 12.43 | 12.4 | 5.9 | 6.2 | ||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1722.72 | 387.9 | 443.6 | 432.7 | ||||||||||||||||||||
Deferred Revenue Non Current | 17.72 | 0 | 4.7 | 7.3 | ||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | -17.72 | - | - | - | ||||||||||||||||||||
balance-sheet.row.other-current-liab | 513.63 | 131.8 | 110.1 | 117.1 | ||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 1830.25 | 450 | 462.1 | 451.8 | ||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 227.27 | 48.9 | 60.1 | 50.8 | ||||||||||||||||||||
balance-sheet.row.total-liab | 2465.01 | 617.7 | 601.1 | 597.8 | ||||||||||||||||||||
balance-sheet.row.preferred-stock | 6.77 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.common-stock | 11.48 | 2.9 | 2.8 | 2.8 | ||||||||||||||||||||
balance-sheet.row.retained-earnings | -10548.38 | -2684.1 | -2532.5 | -2295.9 | ||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -4.04 | 5.3 | -12.1 | 5 | ||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 11041.73 | 2836 | 2664.8 | 2595.5 | ||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 507.56 | 160.2 | 123 | 307.4 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 2972.58 | 777.9 | 724.2 | 905.1 | ||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||
balance-sheet.row.total-equity | 507.56 | 160.2 | 123 | 307.4 | ||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 2972.58 | - | - | - | ||||||||||||||||||||
Total Investments | 220.09 | 42.3 | 144.8 | 237.3 | ||||||||||||||||||||
balance-sheet.row.total-debt | 1803.53 | 445.1 | 452.1 | 440.1 | ||||||||||||||||||||
balance-sheet.row.net-debt | 921.3 | 198.1 | 303.3 | 194.9 |
Отчет за паричните потоци
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | -151.58 | -151.6 | -236.6 | -250.5 | |||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 7.87 | 7.9 | 5.3 | 6.2 | |||||||||||||||||||
cash-flows.row.deferred-income-tax | -9.97 | -4.9 | 0 | 0 | |||||||||||||||||||
cash-flows.row.stock-based-compensation | 86.08 | 86.1 | 76.5 | 57.8 | |||||||||||||||||||
cash-flows.row.change-in-working-capital | -40.05 | -48 | -39.9 | -18.6 | |||||||||||||||||||
cash-flows.row.account-receivables | -20.11 | -20.1 | -17.3 | -8.2 | |||||||||||||||||||
cash-flows.row.inventory | -44.61 | -44.6 | -5.3 | -7.8 | |||||||||||||||||||
cash-flows.row.account-payables | 49.19 | 49.2 | -6.4 | 7.4 | |||||||||||||||||||
cash-flows.row.other-working-capital | -24.53 | -32.5 | -10.8 | -10 | |||||||||||||||||||
cash-flows.row.other-non-cash-items | 38.57 | 41.5 | 28 | 2.5 | |||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -69.09 | 0 | 0 | 0 | |||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -7.44 | -7.4 | -3.8 | -3.9 | |||||||||||||||||||
cash-flows.row.acquisitions-net | -12.2 | 0 | 3.4 | 3.9 | |||||||||||||||||||
cash-flows.row.purchases-of-investments | -91.72 | -91.7 | -243.3 | -341.4 | |||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 197.23 | 197.2 | 335.9 | 424 | |||||||||||||||||||
cash-flows.row.other-investing-activites | 12.2 | 0 | 0 | -3.9 | |||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 98.06 | 98.1 | 92.3 | 78.8 | |||||||||||||||||||
cash-flows.row.debt-repayment | -20.96 | -21 | -0.3 | -0.5 | |||||||||||||||||||
cash-flows.row.common-stock-issued | 95.35 | 103.2 | 4.3 | 199.8 | |||||||||||||||||||
cash-flows.row.common-stock-repurchased | -17.92 | 0 | -11.5 | -15 | |||||||||||||||||||
cash-flows.row.dividends-paid | 0 | 0 | -4.3 | -15 | |||||||||||||||||||
cash-flows.row.other-financing-activites | 7.19 | -20.6 | 4.3 | 42.8 | |||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 61.68 | 61.7 | -7.5 | 212.1 | |||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 6.31 | 6.3 | -14.6 | -5 | |||||||||||||||||||
cash-flows.row.net-change-in-cash | 96.83 | 98.2 | -96.3 | 83.3 | |||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 892.58 | 247 | 153.1 | 249.5 | |||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 795.75 | 148.8 | 249.5 | 166.2 | |||||||||||||||||||
cash-flows.row.operating-cash-flow | -69.09 | -69.1 | -166.6 | -202.5 | |||||||||||||||||||
cash-flows.row.capital-expenditure | -7.44 | -7.4 | -3.8 | -3.9 | |||||||||||||||||||
cash-flows.row.free-cash-flow | -76.53 | -76.5 | -170.3 | -206.4 |
Ред за отчет за приходите
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 399.36 | 399.4 | 329.2 | 305.5 | |||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 39.51 | 45.2 | 38.6 | 34.5 | |||||||||||||||||||||
income-statement-row.row.gross-profit | 359.85 | 354.2 | 290.6 | 271 | |||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||||||||
income-statement-row.row.research-development | 152.38 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-expenses | -8.69 | -15.9 | 5.3 | 6.2 | |||||||||||||||||||||
income-statement-row.row.operating-expenses | 431.11 | 427.7 | 495.1 | 471 | |||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 470.62 | 472.9 | 533.7 | 505.4 | |||||||||||||||||||||
income-statement-row.row.interest-income | 7.08 | 7.1 | 3 | 0.5 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24.18 | 50.1 | 37.1 | 32.5 | |||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | -63.86 | -76.6 | -37.6 | -41.6 | |||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -8.69 | -15.9 | 5.3 | 6.2 | |||||||||||||||||||||
income-statement-row.row.total-operating-expenses | -63.86 | -76.6 | -37.6 | -41.6 | |||||||||||||||||||||
income-statement-row.row.interest-expense | 24.18 | 50.1 | 37.1 | 32.5 | |||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 4.13 | 7.9 | 12.5 | 3.8 | |||||||||||||||||||||
income-statement-row.row.ebitda-caps | -94.93 | - | - | - | |||||||||||||||||||||
income-statement-row.row.operating-income | -76.96 | -73.5 | -204.4 | -199.9 | |||||||||||||||||||||
income-statement-row.row.income-before-tax | -150.1 | -150.1 | -242 | -241.6 | |||||||||||||||||||||
income-statement-row.row.income-tax-expense | 7.74 | 1.5 | -5.5 | 8.9 | |||||||||||||||||||||
income-statement-row.row.net-income | -151.58 | -151.6 | -236.6 | -250.5 |
Често задавани въпроси
Какво е Amicus Therapeutics, Inc. (FOLD) общи активи?
Amicus Therapeutics, Inc. (FOLD) общите активи са 777880000.000.
Какъв е годишният приход на предприятието?
Годишните приходи са 218583000.000.
Какъв е маржът на печалбата на предприятието?
Маржът на печалбата на фирмата е -0.261.
Какъв е свободният паричен поток на компанията?
Свободният паричен поток е -0.261.
Какъв е маржът на нетната печалба на предприятието?
Маржът на нетната печалба е -0.380.
Какъв е общият приход на предприятието?
Общият приход е -0.193.
Каква е Amicus Therapeutics, Inc. (FOLD) нетна печалба (нетен доход)?
Нетната печалба (нетният доход) е -151584000.000.
Какъв е общият дълг на фирмата?
Общият дълг е 445059000.000.
Какъв е броят на оперативните разходи?
Оперативните разходи са 427651000.000.
Какъв е броят на паричните средства на фирмата?
Паричните средства на предприятието са 246994000.000.